🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicenter, randomized, double-blind, placebo-controlled phase I...
Status
Completed
Location
Nanjing Drum Tower Hospital
Start Date
2023-01-06
Trial ID
NCT05628311
A multicenter, randomized, double-blind, placebo-controlled clinical study ...
Status
Recruiting
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2026-04-23
Trial ID
NCT07469800
This trial is conducted in China. The aim of this trial is to investigate S...
Status
Completed
Location
Peking University people's hospital
Start Date
2020-06-16
Trial ID
NCT04440345
This is a multicenter, double-blind, randomized, placebo-controlled study c...
Status
Completed
Location
Peking University people's hospital
Start Date
2021-06-08
Trial ID
NCT04904913
The purpose of this study is to evaluate the safety of LY3305677 and any si...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician.
Start Date
2016-12-05
Trial ID
NCT02972645
The LIGHT-COG study is a 76-week, multicenter, randomized, double-blind, pl...
Status
Recruiting
Location
Department of Endocrinology, Xiangya Hospital of Central South University
Start Date
2025-09-27
Trial ID
NCT07083154
The main purpose of this study, performed under a master protocol W8M-MC-CW...
Status
Completed
Location
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa
Start Date
2023-11-17
Trial ID
NCT06124807
The purpose of this study is to assess how fast IBI362 gets into the blood ...
Status
Completed
Location
Aerospace Center Hospital
Start Date
2023-05-05
Trial ID
NCT05793450
Treatments Being Tested
This is a multicenter, randomized, double-blind, placebo-controlled Phase I...
Status
Recruiting
Location
Peking University Third Hospital
Start Date
2025-06-12
Trial ID
NCT06931028
This is a multicenter, randomized, open-label Phase 3 clinical study compar...
Status
Active Not Recruiting
Location
Beijing Hospital
Start Date
2025-05-09
Trial ID
NCT06884293
Treatments Being Tested